Cardiopulmonary Stress Testing Systems Market

• 1. Preface
• 2. Assumptions and Research Methodology
• 3. Executive Summary: Global Market
• 4. Market Overview
• 5. Global Market Analysis and Forecasts, By Product Type
  • 5.1. Cardiopulmonary Exercise Testing (CPET) Systems
  • 5.2. Stress ECG
  • 5.3. Pulse Oximeters
  • 5.4. Stress Blood Pressure Monitors
  • 5.5. Single-Photon Emission Computed Tomography (SPECT)
• 6. Global Market Analysis and Forecasts, By End-user
  • 6.1. Hospitals
  • 6.2. Specialty Clinics/Cardiology Clinics
  • 6.3. Ambulatory Surgical Centers
  • 6.4. Diagnostic Centers
• 7. Global Market Analysis and Forecasts, By Region
  • 7.1. North America
  • 7.2. Europe
  • 7.3. Asia Pacific
  • 7.4. Latin America
  • 7.5. Middle East and Africa
• 8. North America Market Analysis and Forecast
• 9. Europe Market Analysis and Forecast
• 10. Asia Pacific Market Analysis and Forecast
• 11. Latin America Market Analysis and Forecast
• 12. Middle East and Africa Market Analysis and Forecast
• 13. Competition Landscape
  • 13.1. Koninklijke Philips N.V.
  • 13.2. Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)
  • 13.3. General Electric Company (GE Healthcare)
  • 13.4. MGC Diagnostics Corporation
  • 13.5. OSI Systems, Inc. (Spacelabs Healthcare)
  • 13.6. Masimo
  • 13.7. NIHON KOHDEN CORPORATION
  • 13.8. COSMED
  • 13.9. Halma plc (SunTech Medical, Inc.)
  • 13.10. Schiller AG
  • 13.11. Vyaire Medical, Inc.

Table 01: Medical Device Classification as per U.S. FDA

Table 02: Code of Federal Regulations, by Type of Device

Table 03: Supplements for Pre-market Approval, by Type of Supplement, 1986 to 1997

Table 04: Medical Device Classification as per European Commission (EC)

Table 05: Global Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 06: Global Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 07: Global Market Size (US$ Mn) Forecast, by Region, 2023 to 2033

Table 08: North America Market Value (US$ Mn) Forecast, by Country, 2023 to 2033

Table 09: North America Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 10: North America Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 11: Europe Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 12: Europe Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 13: Europe Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 14: Asia Pacific Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 15: Asia Pacific Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 16: Asia Pacific Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 17: Latin America Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 18: Latin America Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 19: Latin America Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Table 20: Middle East & Africa Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023 to 2033

Table 21: Middle East & Africa Market Value (US$ Mn) Forecast, by Product Type, 2023 to 2033

Table 22: Middle East & Africa Market Value (US$ Mn) Forecast, by End-user, 2023 to 2033

Figure 01: Global Market Value (US$ Mn) Forecast, 2023 to 2033

Figure 02: Global Market Value Share, by Product (2022)

Figure 03: Global Market Value Share, by Region (2022)

Figure 04: Global Market Value Share, by End-user (2022)

Figure 05: FDA Review Process for 2022

Figure 06: Deaths per Mn Population Caused by Cardiovascular Diseases, by Country, 2012

Figure 07: Global Market Value Share, by Product Type, 2023 and 2033

Figure 08: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cardiopulmonary Exercise Testing (CPET) Systems, 2023 to 2033

Figure 09: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stress ECG, 2023 to 2033

Figure 10: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Pulse Oximeters, 2023 to 2033

Figure 11: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Stress Blood Pressure Monitors, 2023 to 2033

Figure 12: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Single-Photon Emission Computed Tomography (SPECT), 2023 to 2033

Figure 13: Global Market Attractiveness, by Product Type, 2023 to 2033

Figure 14: Global Market Value Share, by End-user, 2023 and 2033

Figure 15: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2023 to 2033

Figure 16: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Specialty Clinics/ Cardiology Clinics, 2023 to 2033

Figure 17: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ambulatory Surgical Centers, 2023 to 2033

Figure 18: Global Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diagnostic Centers, 2023 to 2033

Figure 19: Global Market Attractiveness, by End-user, 2023 to 2033

Figure 20: Global Market Value Share, by Region, 2023 and 2033

Figure 21: Global Market Attractiveness, by Region, 2023 to 2033

Figure 22: North America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 23: North America Market Value Share, by Country, 2023 and 2033

Figure 24: North America Market Attractiveness, by Country, 2023 to 2033

Figure 25: North America Market Value Share, by Product Type, 2023 and 2033

Figure 26: North America Market Attractiveness, by Product Type, 2023 to 2033

Figure 27: North America Market Value Share, by End-user, 2023 and 2033

Figure 28: North America Market Attractiveness, by End-user, 2023 to 2033

Figure 29: Europe Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 30: Europe Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 31: Europe Market Attractiveness, by Country/Sub-region, 2023 to 2033

Figure 32: Europe Market Value Share, by Product Type, 2023 and 2033

Figure 33: Europe Market Attractiveness, by Product Type, 2023 to 2033

Figure 34: Europe Market Value Share, by End-user, 2023 and 2033

Figure 35: Europe Market Attractiveness, by End-user, 2023 to 2033

Figure 36: Asia Pacific Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 37: Asia Pacific Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 38: Asia Pacific Market Attractiveness, by Country/Sub-region, 2023 to 2033

Figure 39: Asia Pacific Market Value Share, by Product Type, 2023 and 2033

Figure 40: Asia Pacific Market Attractiveness, by Product Type, 2023 to 2033

Figure 41: Asia Pacific Market Value Share, by End-user, 2023 and 2033

Figure 42: Asia Pacific Market Attractiveness, by End-user, 2023 to 2033

Figure 43: Latin America Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 44: Latin America Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 45: Latin America Market Attractiveness, by Country/Sub-region, 2023 to 2033

Figure 46: Latin America Market Value Share, by Product Type, 2023 and 2033

Figure 47: Latin America Market Attractiveness, by Product Type, 2023 to 2033

Figure 48: Latin America Market Value Share, by End-user, 2023 and 2033

Figure 49: Latin America Market Attractiveness, by End-user, 2023 to 2033

Figure 50: Middle East & Africa Market Value (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2023 to 2033

Figure 51: Middle East & Africa Market Value Share, by Country/Sub-region, 2023 and 2033

Figure 52: Middle East & Africa Market Attractiveness, by Country/Sub-region, 2023 to 2033

Figure 53: Middle East & Africa Market Value Share, by Product Type, 2023 and 2033

Figure 54: Middle East & Africa Market Attractiveness, by Product Type, 2023 to 2033

Figure 55: Middle East & Africa Market Value Share, by End-user, 2023 and 2033

Figure 56: Middle East & Africa Market Attractiveness, by End-user, 2023 to 2033

Figure 57: Global Market Share, by Company, 2022

Figure 58: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Koninklijke Philips N.V.

Figure 59: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Koninklijke Philips N.V.

Figure 60: Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Koninklijke Philips N.V.

Figure 61: Breakdown of Net Sales (%), by Region, 2022, Koninklijke Philips N.V.

Figure 62: Breakdown of Net Sales (%), by Business Segment, 2022, Koninklijke Philips N.V.

Figure 63: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)

Figure 64: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)

Figure 65: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Hill-Rom Holdings, Inc. (Welch Allyn & Mortara Instrument, Inc.)

Figure 66: Breakdown of Net Sales (%), by Region, 2022 (Hill-Rom Holdings, Inc.)

Figure 67: Breakdown of Net Sales (%), by Business Segment, 2022 (Hill-Rom Holdings, Inc.)

Figure 68: Breakdown of Net Sales (%), by Region, 2018 (Welch Allyn)

Figure 69: Breakdown of Net Sales (~ %), by Business Segments, 2022 (Mortara Instrument, Inc.)

Figure 70: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, General Electric Company (GE Healthcare)

Figure 71: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, General Electric Company (GE Healthcare)

Figure 72: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, General Electric Company (GE Healthcare)

Figure 73: Breakdown of Net Sales (%), by Region, 2022, General Electric Company (GE Healthcare)

Figure 74: Breakdown of Net Sales (%), by Business Segment, 2022, General Electric Company (GE Healthcare)

Figure 75: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, MGC Diagnostics Corporation

Figure 76: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, MGC Diagnostics Corporation

Figure 77: Sales & Marketing Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, MGC Diagnostics Corporation

Figure 78: Breakdown of Net Sales (%), by Region, 2022, MGC Diagnostics Corporation

Figure 79: Breakdown of Net Sales (%), by Business Segment, 2022, MGC Diagnostics Corporation

Figure 80: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, OSI Systems, Inc. (Spacelabs Healthcare)

Figure 81: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, OSI Systems, Inc. (Spacelabs Healthcare)

Figure 82: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, OSI Systems, Inc. (Spacelabs Healthcare)

Figure 83: Breakdown of Net Sales (%), by Region, 2022, OSI Systems, Inc. (Spacelabs Healthcare)

Figure 84: Breakdown of Net Sales (%), by Business Segment, 2022, OSI Systems, Inc. (Spacelabs Healthcare)

Figure 85: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Masimo

Figure 86: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Masimo

Figure 87: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Masimo

Figure 88: Breakdown of Net Sales (%), by Region, 2022, Masimo

Figure 89: Installed Base (Estimated Units) and Y-o-Y Growth (%), 2018 to 2022, Masimo

Figure 90: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, NIHON KOHDEN CORPORATION

Figure 91: R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, NIHON KOHDEN CORPORATION

Figure 92: Selling and Administrative Expenses (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, NIHON KOHDEN CORPORATION

Figure 93: Breakdown of Net Sales (%), by Region, 2022, NIHON KOHDEN CORPORATION

Figure 94: Breakdown of Net Sales (%), by Business Segment, 2022, NIHON KOHDEN CORPORATION

Figure 95: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Halma plc (SunTech Medical, Inc.)

Figure 96: Revenue (US$ Mn) and Y-o-Y Growth (%), 2018 to 2022, Halma plc (SunTech Medical, Inc.)

Figure 97: Breakdown of Net Sales (%), by Business Segment, 2022, Halma plc (SunTech Medical, Inc.)